Plain-English translation of NCT06003036 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial examined whether accelerated repetitive transcranial magnetic stimulation (a non-invasive brain stimulation technique) could enhance thinking, memory, and cognitive abilities in people with schizophrenia or schizoaffective disorder who were already being treated with clozapine. Participants received baseline brain imaging and cognitive testing, then attended two separate sessions—one with real brain stimulation and one with a sham (fake) version—to compare how the treatment affected their brain function and thinking skills.
Clozapine is an effective antipsychotic medication, but it doesn't help everyone improve their thinking and memory abilities equally. Researchers wanted to see whether adding brain stimulation to this medication could boost these cognitive improvements in people whose symptoms had not fully responded to other antipsychotic treatments.
Participants came in for an initial visit with brain imaging (MRI) and cognitive testing. They then attended two separate sessions in random order: one where they received real brain stimulation followed by an MRI scan, and another where they received sham (fake) stimulation followed by an MRI scan. Neither the participant nor the study staff knew which session came first, ensuring the test was fair. The study aimed to compare how real versus fake stimulation affected thinking and brain activity.
AI-generated summary from trial data · Aug 25, 2026 · Not medical advice
United States